Yu Akahoshi¹, Shuichi Mizuta², Hiroaki Shimizu³, Naoyuki Uchida⁴, Takahiro Fukuda⁵, Heiwa Kanamori⁶, Makoto Onizuka⁷, Yukiyasu Ozawa⁸, Junji Tanaka⁹, Yoshiko Atsuta¹⁰, Shinichi Kako¹ (1.Hematol., Saitama Medical Center., Jichi Medical Univ., Saitama, Japan, 2.Department of Hematology and Immunology, Kanazawa Medical University, 3.Hematol., Gunma University Graduate School of Medicine, 4.Department of Hematology, Toranomon Hospital, 5.Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 6.Department of Hematology, Kanagawa Cancer Center, 7.Department of Hematology/Oncology, Tokai University School of Medicine, 8.Department of Hematology, Japanese Red Cross Nagoya First Hospital, 9.Department of Hematology, Tokyo Women's Medical University, 10.Japanese Data Center for Hematopoietic Cell Transplantation)

Takayoshi Tachibana¹, Takuma Ishizaki², Satoshi Takahashi³, Noriko Doki⁴, Shun-Ichi Kimura⁵, Emiko Sakaida⁶, Makoto Onizuka⁷, Takehiko Mori⁸, Shin Fujisawa⁹, Shin-Ichiro Fujiwara¹⁰, Takeshi Saito¹¹, Maki Hagihara¹², Nobuyuki Aotsuka¹³, Moritaka Gotoh¹⁴, Kensuke Usuki¹⁵, Nobuhiro Tsukada¹⁶, Yoshinobu Kanda^5,10, Heiwa Kanamori¹, Shinichiro Okamoto⁸ (1.Dep. Hematology, Kanagawa Cancer Center, Yokohama, Japan, 2.Dep. Medicine and Clinical Science, Gunma University, Maebashi, Japan, 3.Dep. Hematology/Oncology, The Institute of Medical Science, Tokyo Univ., 4.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 5.Div. Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan, 6.Department of Hematology, Chiba University Hospital, Chiba, Japan, 7.Dep. Hematology/Oncology, Tokai University, Isehara, Japan, 8.Div. Hematology, Dep. Medicine, Keio University, Tokyo, Japan, 9.Dep. Hematology, Yokohama City University Medical Center, Yokohama, Japan, 10.Div. Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan, 11.Div. Clinical Oncology/Hematology, Jikei University, Tokyo, Japan, 12.Dep. Hematology and Clinical Immunology, Yokohama City University, Yokohama, Japan, 13.Div. Hematology/Oncology, Japanese Red Cross Society Narita Hospital, Narita, Japan, 14.First Department of Internal Medicine, Tokyo Medical University,Tokyo, Japan, 15.Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan, 16.Dep. Hematology, Japanese Red Cross Medical Center, Tokyo, Japan)

Koji Iwato¹, Yuta Katayama², Ryota Imanaka², Kohei Kyo², Mitsuhiro Itagaki², Takeshi Okatani², Tatsuji Mino², Shinya Katsutani², Hideki Asaoku² (1.Clinical Lab. Hiroshima Red Cross Hosp.., Hiroshima,Japan, 2.Hematol. Hiroshima Red Cross Hosp.., Hiroshima,Japan)

Tatsuya Konishi, Noriko Doki, Yuya Kishida, Akihito Nagata, Yuta Yamada, Satoshi Kaito, Shuhei Kurosawa, Kota Yoshifuji, Shuichi Shirane, Tomoyuki Uchida, Kyoko Inamoto, Takashi Toya, Aiko Igarashi, Yuho Najima, Takeshi Kobayashi, Kazuhiko Kakihana, Hisashi Sakamaki, Kazuteru Ohashi (Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan)

Jun Aoki¹, Shin Fujisawa¹, Shuichi Mizuta², Yukiyasu Ozawa³, Kazuteru Ohashi⁴, Shuichi Ota⁵, Hiroyasu Ogawa⁶, Takahiro Fukuda⁷, Naoyuki Uchida⁸, Junji Tanaka⁹, Yoshiko Atsuta¹⁰, Shinichi Kako¹¹ (1.Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan, 2.Department of Hematology and Immunology, Kanazawa Medical University, Kanazawa, Japan, 3.Department of Hematology, Red Cross Nagoya First Hospital, Nagoya, Japan, 4.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 5.Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan, 6.Division of Hematology, Hyogo College of Medicine, Nishinomiya, Japan, 7.Department of HSCT, National Cancer Center Hospital, Tokyo, Japan, 8.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 9.Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan, 10.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 11.Division of Hematology, Saitama Medical Center, Jichi University, Omiya, Japan)

Sousuke Nakamura¹, Kazuaki Yokoyama^1,2, Nozomi Yusa³, Kanya Kondoh¹, Miho Ogawa¹, Tomomi Takei¹, Asako Kobayashi¹, Mika Ito¹, Koji Jimbo^1,2, Susumu Tanoue², Masamichi Isobe², Takaaki Konuma², Seiko Kato², Eigo Shimizu⁴, Rika Kasajima⁵, Yuka Wada⁶, Rui Yamaguchi⁴, Seiya Imoto⁵, Tokiko Nagamura-Inoue⁶, Satoshi Takahashi¹, Satoru Miyano^4,5, Arinobu Tojo^1,2 (1.Division of Molecular Therapy, IMSUT, University of Tokyo, 2.Department of Hematology/Oncology, IMSUT Hospital, University of Tokyo, 3.Department of Applied Genomics, IMSUT Hospital, University of Tokyo, 4.Laboratory of DNA Information Analysis, IMSUT, University of Tokyo, 5.Health Intelligence Center, IMSUT, University of Tokyo, 6.Department of Cell Processing and Transfusion, IMSUT, University of Tokyo)